UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model

British journal of cancer, 2012-06, Vol.106 (12), p.1945-1952

2012

Volltextzugriff (PDF)

Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study

British journal of cancer, 2005-10, Vol.93 (9), p.1019-1023

2005

Volltextzugriff (PDF)

Hsp27 silencing coordinately inhibits proliferation and promotes Fas-induced apoptosis by regulating the PEA-15 molecular switch

Cell death and differentiation, 2012-06, Vol.19 (6), p.990-1002

2012

Volltextzugriff (PDF)

Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides

JNCI : Journal of the National Cancer Institute, 2000-01, Vol.92 (1), p.34-41

2000

Volltextzugriff (PDF)

Surgical placement of rectus sheath catheters in a cadaveric cystectomy model

Annals of the Royal College of Surgeons of England, 2018-02, Vol.100 (2), p.120-124

2018

Volltextzugriff (PDF)

GRP78 regulates clusterin stability, retrotranslocation and mitochondrial localization under ER stress in prostate cancer

Oncogene, 2013-04, Vol.32 (15), p.1933-1942

2013

Volltextzugriff (PDF)

International multicentre study examining selection criteria for active surveillance in men undergoing radical prostatectomy

British journal of cancer, 2012-10, Vol.107 (9), p.1467-1473

2012

Volltextzugriff (PDF)

Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer

Cancer research (Chicago, Ill.), 2000, Vol.60 (1), p.170-176

2000

Volltextzugriff (PDF)

A phase I dose-escalation study of apatorsen (OGX-427), an antisense inhibitor targeting heat shock protein 27 (Hsp27), in patients with castration-resistant prostate cancer and other advanced cancers

Annals of oncology, 2016-06, Vol.27 (6), p.1116-1122

2016

Volltextzugriff (PDF)

EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER

The Journal of urology, 2004-09, Vol.172 (3), p.915-919

2004

Volltextzugriff (PDF)

Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene Testosterone-repressed prostate message-2 in prostate cancer xenograft models

Cancer research (Chicago, Ill.), 2000-05, Vol.60 (9), p.2547-2554

2000

Volltextzugriff (PDF)

Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells

British journal of cancer, 2009-11, Vol.101 (10), p.1731-1739

2009

Volltextzugriff (PDF)

Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models

Cancer research (Chicago, Ill.), 2000-06, Vol.60 (11), p.3058-3064

2000

Volltextzugriff (PDF)

Multimodal approaches to high-risk prostate cancer

Current oncology (Toronto), 2010-09, Vol.17 Suppl 2 (12), p.S33-37

2010

Volltextzugriff (PDF)

Detection of circulating tumor DNA in de novo metastatic castrate sensitive prostate cancer

Annals of oncology, 2018-10, Vol.29, p.viii273-viii273

2018

Volltextzugriff (PDF)

Biochemical and Pathological Effects of 8 Months of Neoadjuvant Androgen Withdrawal Therapy Before Radical Prostatectomy in Patients with Clinically Confined Prostate Cancer

The Journal of urology, 1996, Vol.155 (1), p.213-219

1996

Volltextzugriff (PDF)

Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies

Prostate cancer and prostatic diseases, 2016-09, Vol.19 (3), p.264-270

2016

Volltextzugriff (PDF)

Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model

BJU international, 2003-09, Vol.92 (4), p.463-469

2003

Volltextzugriff (PDF)

Derivation of androgen‐independent human LNCaP prostatic cancer cell sublines: Role of bone stromal cells

International journal of cancer, 1994-05, Vol.57 (3), p.406-412

1994

Volltextzugriff (PDF)

Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells

Cancer research (Chicago, Ill.), 2000-10, Vol.60 (20), p.5825-5831

2000

Volltextzugriff (PDF)

Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy

World journal of urology, 2016-01, Vol.34 (1), p.41-48

2016

Volltextzugriff (PDF)

Plasma miR-371a-3p for detection of non-teratomatous viable germ cell tumor in testicular cancer

Annals of oncology, 2018-10, Vol.29, p.viii323-viii324

2018

Volltextzugriff (PDF)

Inhibition of progression to androgen‐independence by combined adjuvant treatment with antisense BCL‐XL and antisense Bcl‐2 oligonucleotides plus taxol after castration in the Shionogi tumor model

International journal of cancer, 2000-06, Vol.86 (6), p.855-862

2000

Volltextzugriff (PDF)

The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel

Cancer research (Chicago, Ill.), 2000-08, Vol.60 (15), p.4146-4151

2000

Volltextzugriff (PDF)

1 – 25 von 411

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(368)
Mit Volltextzugriff
(332)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model

Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study

Hsp27 silencing coordinately inhibits proliferation and promotes Fas-induced apoptosis by regulating the PEA-15 molecular switch

Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides

Surgical placement of rectus sheath catheters in a cadaveric cystectomy model

GRP78 regulates clusterin stability, retrotranslocation and mitochondrial localization under ER stress in prostate cancer

International multicentre study examining selection criteria for active surveillance in men undergoing radical prostatectomy

Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer

A phase I dose-escalation study of apatorsen (OGX-427), an antisense inhibitor targeting heat shock protein 27 (Hsp27), in patients with castration-resistant prostate cancer and other advanced cancers

EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER

Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene Testosterone-repressed prostate message-2 in prostate cancer xenograft models

Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells

Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models

Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality

Multimodal approaches to high-risk prostate cancer

Detection of circulating tumor DNA in de novo metastatic castrate sensitive prostate cancer

Biochemical and Pathological Effects of 8 Months of Neoadjuvant Androgen Withdrawal Therapy Before Radical Prostatectomy in Patients with Clinically Confined Prostate Cancer

Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies

Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model

Derivation of androgen‐independent human LNCaP prostatic cancer cell sublines: Role of bone stromal cells

Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells

Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy

Plasma miR-371a-3p for detection of non-teratomatous viable germ cell tumor in testicular cancer

Inhibition of progression to androgen‐independence by combined adjuvant treatment with antisense BCL‐XL and antisense Bcl‐2 oligonucleotides plus taxol after castration in the Shionogi tumor model

The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel

Suchergebnisse filtern